For Research Use Only
Selank is a synthetic 7-amino-acid regulatory peptide developed from the endogenous immunomodulatory peptide tuftsin.
Its structure incorporates the tuftsin sequence Thr-Lys-Pro-Arg with the addition of Pro-Gly-Pro, which was designed to improve metabolic stability.
Selank has been investigated primarily for its effects on GABAergic neurotransmission, stress-response pathways, cognition, neuroplasticity, monoamine signaling, and neuroimmune regulation.
Selank has been investigated in research involving:
Research includes cellular and animal experiments as well as a relatively small body of human studies, much of which originates from Russia.
Selank’s precise mechanism has not been fully established.
One of the primary research areas involves the GABAergic system, the brain’s major inhibitory neurotransmitter network.
Experimental research has demonstrated changes in the expression of genes associated with:
This has led researchers to investigate a general pathway involving:
Selank → GABAergic Modulation → Neurotransmission → Stress & Behavioral Responses
Rat studies have shown that Selank can alter expression of numerous genes involved in neurotransmission, supporting the hypothesis that its effects involve complex regulation rather than a single receptor target.
The relationship between Selank and GABA signaling is one of its most studied characteristics.
GABA is the primary inhibitory neurotransmitter in the central nervous system and plays an important role in:
Experimental research suggests Selank may influence GABAergic neurotransmission and gene expression associated with this system. However, it should not simply be described as a benzodiazepine or direct GABA-A agonist, because its molecular actions remain incompletely characterized.
Selank has also attracted interest for potential relationships with:
These areas have led Selank to sometimes be described as a nootropic research peptide, although evidence supporting cognitive enhancement in healthy humans remains limited. A recent review describes potential involvement of BDNF and monoaminergic signaling while emphasizing the relatively limited evidence base outside Russia.
Selank’s relationship to tuftsin gives it another interesting dimension.
Tuftsin is an endogenous immunomodulatory peptide associated with immune-cell activity. Selank has consequently been investigated for potential interactions between:
Immune Signaling ↔ Nervous System ↔ Stress Response
Research has explored changes involving immune regulation and neuroimmune communication alongside its neurological effects.
Selank is particularly interesting because it sits at the intersection of several biological systems:
Rather than functioning as a conventional stimulant or sedative, researchers investigate how Selank may modify the neural networks involved in stress adaptation and inhibitory neurotransmission.
A small 60-person Russian clinical study compared Selank with phenazepam in people with anxiety-spectrum disorders and reported anxiolytic effects and tolerability. However, this limited evidence base is not equivalent to large, independently replicated modern clinical trials.
✔ Premium Research Grade
✔ High-Purity Selank
✔ 7-Amino-Acid Regulatory Peptide
✔ Third-Party Tested (COA Available)
✔ Identity & Purity Verification
✔ Secure Professional Packaging
✔ Laboratory Research Only
Researchers may investigate Selank in studies involving:
Store according to the product’s batch-specific stability documentation.
Protect lyophilized material from excessive heat, moisture, and direct sunlight.
Following preparation for laboratory experiments, use validated laboratory storage procedures and minimize unnecessary temperature cycling or repeated freeze-thaw exposure.
For Research Use Only.
Selank is not an FDA-approved drug in the United States. Although human research has been reported and Selank has a history of use in Russia, the overall evidence base remains substantially smaller than that required to establish broad clinical safety and effectiveness under U.S. regulatory standards.
This Voltis product is intended exclusively for laboratory research and analytical purposes.
Not intended for human or veterinary use.
At Voltis Research Co., quality begins with verification. Researchers deserve confidence that the compound identified on every vial accurately represents the material being investigated.
Qualifying batches undergo independent third-party analytical testing, with batch-specific Certificates of Analysis available to document identity and purity.
⚡ Research-Grade Quality
⚡ Independent Third-Party Testing
⚡ Batch-Specific Certificate of Analysis (COA)
⚡ High-Purity Research Peptides
⚡ Rigorous Quality Control
⚡ Secure Professional Packaging
⚡ Transparency, Consistency & Reliability
Powering Discovery Through Quality Research.
$50.00
Related Products
Voltis supplies peptides and research compounds intended for laboratory and research purposes only.
These products are not approved for human consumption and have not been evaluated by the FDA.
By entering this website, you acknowledge that you are at least 21 years of age and understand the intended use of these products.
Added to cart
Check out our shop to see what's available